| mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-08 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.22 |
3e-06 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
9e-06 |
| mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |